167 results
Page 4 of 9
8-K
EX-99.1
3rq2wkqht ivaiwktd7t
5 Nov 20
FibroGen Reports THIRD Quarter 2020 Financial Results
4:05pm
8-K
EX-99.1
pxy2ro
6 Aug 20
FibroGen Reports SECOND Quarter 2020 Financial Results
4:10pm
8-K
EX-99.1
1mucysckbl6olt3xoq
6 Aug 20
FibroGen Announces New Appointments to its Board of Directors
4:06pm
8-K
EX-99.1
g2q6 2akb
7 May 20
FibroGen Reports First Quarter 2020 Financial Results
4:09pm
8-K
EX-99.1
3xhyfudl6ocsyk7sdhg
24 Mar 20
Master Supply Agreement
5:24pm
8-K
EX-99.1
uje57du
2 Mar 20
FibroGen Reports Fourth Quarter and Full Year 2019 Financial Results
4:06pm
8-K
kk38ptxogp5
11 Feb 20
FibroGen Announces U.S. FDA Acceptance of New Drug Application for Roxadustat for the Treatment of Anemia of Chronic Kidney Disease
5:16pm
8-K
EX-99.1
j21cmg
11 Feb 20
FibroGen Announces U.S. FDA Acceptance of New Drug Application for Roxadustat for the Treatment of Anemia of Chronic Kidney Disease
5:16pm
8-K
EX-99.1
opjetul
30 Jan 20
Astellas Submits Supplemental New Drug Application for Approval of
4:40pm
8-K
7br yko7h
30 Jan 20
Astellas Submits Supplemental New Drug Application for Approval of
4:40pm